Danish Drugmaker Faces Hefty Fine

27th September 2010, Comments 0 comments

The Federal Anti-Monopoly Service accused Danish pharmaceutical company Novo Nordisk of violating anti-monopoly legislation on Friday and said the firm might face a fine of up to 15 percent of its Russian revenue.

0 Comments To This Article